Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 201

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Creatinine as the gold standard for kidney injury biomarker studies?

Waikar, S. S., Betensky, R. A., Bonventre, J. V. · 2009 · Nephrology Dialysis Transplantation

Abstract

Before 2005, when the Acute Dialysis Quality Initiative proposed a consensus definition [ 1 ], acute kidney injury (formerly known as ‘acute renal failure’) was identified by most clinicians in the way that Justice Potter Stewart identified obscenity: they knew it when they saw it. Epidemiologists and clinical researchers, who needed an objective criterion, seemed to devise a different definition for every new study; indeed, over 35 definitions have been used to define AKI in the nephrology literature [ 2 ]. For Homer Smith, who introduced the term ‘acute renal failure’ in his textbook, The Kidney: Structure and Function in Disease and Health [ 3 ], a specific definition did not seem to matter: nowhere in his textbook does he propose a way to define AKI. We know that definitions do matter in modern clinical medicine. The consensus definition of acute myocardial infarction, which has evolved over the years and now requires biochemical evidence of myocardial tissue injury, has facilitated the design and execution of studies that have led to revolutionary changes in the treatment and outcome of patients with acute myocardial infarction around the world. The consensus definitions of sepsis and acute lung injury similarly permitted the critical care community to study and advance the clinical science and management of critically ill patients, with some clear success stories [ 4,5 ]. Within nephrology, the new consensus definition of chronic kidney disease, while controversial, has focused attention on early recognition and staging of the clinical syndrome, influenced clinical trial design as well as referral patterns to nephrologists [ 6 ], and hopefully will provide a tangible benefit for our patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfp428

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 201

Metadata

Authors
Waikar, S. S., Betensky, R. A., & Bonventre, J. V.
Venue
Nephrology Dialysis Transplantation
Published
2009-09-07
Volume
24
Issue
11
Pages
3263-3265
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2160530471
Cited by
201
References
2
FWCI
6.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Creatinine as the gold standard for kidney injury biomarker studies? https://app.cochat.ai/papers/10.1093/ndt/gfp428
The paper
Waikar, S. S., Betensky, R. A., & Bonventre, J. V. (2009). Creatinine as the gold standard for kidney injury biomarker studies? Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfp428

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.